Received Oct 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 7L3ST | — |
Clinic purchaser reported that 2 patients may have received just the diluent; Clinic purchaser reported that 2 patients may have received just the diluent; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate preparation of medication in a specified number of patients who received RSVPreF3 adjuvanted (Arexvy) (batch number 7L3ST, expiry date 30-OCT-2025) for prophylaxis. On an unknown date, the patient received the 1st dose of Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: Clinic purchaser reported that 2 patients may have received just the diluent) and inappropriate dose of vaccine administered (Verbatim: Clinic purchaser reported that 2 patients may have received just the diluent). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date:14-OCT-2025 The clinic purchaser reported that 2 patients might have received just the Arexvy diluent.